[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100620558":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":20,"responsibleParty":38,"collaborators":7,"id":40,"slug":7,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":45,"eligibilityCriteria":46,"healthyVolunteers":41,"sex":47,"minAge":7,"maxAge":7,"enrollmentInfo":48,"targetDuration":7,"studyType":51,"phases":7,"briefSummary":52,"conditions":53,"keywords":7,"overallStatus":23,"whyStopped":7,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"Murdoch Childrens Research Institute","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Adriana Chebar Lozinsky Rolnik","PRINCIPAL_INVESTIGATOR",[13,17],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","61399366435","lpem.study@mcri.edu.au",{"name":18,"role":14,"phone":19,"phoneExt":7,"email":16},"Amanda Burgess","+61383416200",[21],{"facility":22,"status":23,"city":24,"state":25,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"Murdoch Children's Research Institute","RECRUITING","Parkville","Victoria","3052","Australia","AU",{"type":30,"coordinates":31},"Point",[32,33],144.95,-37.78333,{"lat":33,"lon":32},[36,37],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},{"name":10,"role":11,"phone":7,"phoneExt":7,"email":7},{"type":39,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100620558",false,"NCT07359183","A Long Term, Observational Follow-Up Study of Children and Young People Who Underwent an 18-Month Course of Oral Immunotherapy Treatment for Peanut, Egg or Milk Allergy (5-15 Years Post-Treatment)","Long Term Outcomes Associated With Attainment of Remission Following Oral Immunotherapy to Peanut, Egg and Cow's Milk (LPEM Study)","LPEM","Inclusion Criteria:\n\n* Previous participant of PEAT, PrEMO, PPOIT-001 or PPOIT-002 parent study\n* Received at least one dose of OIT treatment in the parent study\n* Written informed consent from participant and\u002For parent\u002Fguardian (if below 18 years of age)\n\nExclusion Criteria:\n\n-Have any conditions that, in the opinion of the investigator, precludes participation for reason of safety","ALL",{"count":49,"type":50},147,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to learn about the long-term outcomes of children and young people who underwent an 18-month course of oral immunotherapy (OIT) treatment for peanut, egg or milk allergy. It aims to:\n\n• Compare long-term changes in health-related quality of life (HRQL) at 5-15 years after stopping OIT in participants who achieved remission and those who did not.\n\nParticipants will attend a single follow-up visit for:\n\n* A blood test\n* Skin prick test (SPT)\n* Allergy questionnaires",[54,55,56,57],"Food Allergies","Peanut Allergies","Egg Allergy","Milk Allergy","2026-01-29",{"date":60,"type":61},"2026-02-02","ACTUAL",{"date":63,"type":61},"2026-01-13",{"date":65,"type":50},"2027-01",{"name":5,"class":6},1]